We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Revolutionizing Surgery with Real-Time Metabolic Profiling

By HospiMedica International staff writers
Posted on 27 Jan 2011
Surgical metabonomics, the metabolic profiling of tissue samples, could transform the way surgeons make decisions in the operating theatre.

Researchers at the Imperial College London (ICL; London, United Kingdom) Surgical Metabonomics Laboratory (SML) are using a high-resolution solid-state nuclear magnetic resonance (NMR) spectrometer to analyze intact tissue samples, without preparation. More...
Surgeons will be able to take tissue samples and have them loaded straight into the NMR machine, receiving a readily interpretable readout from the analysis within 20 minutes, which would provide information such as whether the tissues is infected or how good its blood supply is. Surgeons might also use the technology to determine exactly which areas of tissue are cancerous.

"This is a radical change of approach that doesn't just apply to surgery. We want to be able to provide a metabolic map of the entire patient journey. Before surgery, metabonomics could tell the doctor how risky surgery might be for that patient, or how best to prepare him for surgery,” said Prof. Jeremy Nicholson, PhD, a leading researcher in biomolecular medicine and head of the department of surgery and cancer, who will lead the SML together with surgical innovator Prof. Lord Ara Darzi, MD. "After the operation, metabonomics might help the doctor to monitor the patient's recovery and prescribe the most suitable drugs or diet. Ultimately we hope to apply this approach to every area of medicine.”

"People respond differently to the physical trauma of surgery, but currently the tools we have to measure how they respond are very limited,” added Lord Darzi. "Blood tests are slow and they can only measure one chemical component at a time; the doctor simply looks at whether a particular measure has gone up or down. Using NMR, we can simultaneously measure all of the chemicals that the body is producing, and analyze those data to give the surgeon real-time information about the patient's condition, which will help him make decisions.”

The science of metabonomics involves comprehensively measuring the metabolic changes in a person's body, using techniques from analytical chemistry that allow researchers to measure simultaneously all of the chemicals produced by the body's metabolism. With knowledge of which molecules correspond to which conditions in the body, this "metabolic fingerprint” can provide a wealth of information about the state of a person's health. Metabonomics has previously been applied to samples of bodily fluids (such as blood and urine) to look for indicators of disease or of how a person might respond to a particular drug.

Related Links:
Imperial College London



Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Head Rest
Medifa 61114_3
Half Apron
Demi
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.